1 Guan, W. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Engl J Med 382, 1708-1720, doi:10.1056/NEJMoa2002032 (2020).
2 He, F., Deng, Y. & Li, W. N. Coronavirus disease 2019: What we know? J Med Virol 92, 719-725, doi:10.1002/jmv.25766 (2020).
3 Jiang, F. et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of General Internal Medicine 35, 1545-1549, doi:10.1007/s11606-020-05762-w (2020).
4 Hadi, A. G., Kadhom, M., Hairunisa, N., Yousif, E. & Mohammed, S. A. A Review on COVID-19: Origin, Spread, Symptoms, Treatment, and Prevention. Biointerface Research in Applied Chemistry 10, 7234-7242, doi:10.33263/briac106.7234.7242 (2020).
5 Ou, X. Y. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11, doi:10.1038/s41467-020-15562-9 (2020).
6 Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-+, doi:10.1038/s41586-020-2012-7 (2020).
7 Li, Y. W., Zhou, W., Yang, L. & You, R. Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacological Research 157, doi:10.1016/j.phrs.2020.104833 (2020).
8 Vuille-dit-Bille, R. N., Liechty, K. W., Verrey, F. & Guglielmetti, L. C. SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age. Amino Acids, doi:10.1007/s00726-020-02870-z.
9 Zhang, H. et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 96, 19-24, doi:10.1016/j.ijid.2020.04.027 (2020).
10 Liang, W. C. et al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut 69, 1141-+, doi:10.1136/gutjnl-2020-320832 (2020).
11 Cheung, K. S. et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology 159, 81-95, doi:10.1053/j.gastro.2020.03.065 (2020).
12 Xu, Y. et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med, doi:10.1038/s41591-020-0817-4.
13 Effenberger, M. et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 69, 1543-1544, doi:10.1136/gutjnl-2020-321388 (2020).
14 Daughton, C. G. Wastewater surveillance for population -wide Covid-19: The present and future. Sci Total Environ 736, doi:10.1016/j.scitotenv.2020.139631 (2020).
15 de Lima, C. V. C. et al. Effects of quarantine on mental health of populations affected by Covid-19. Journal of Affective Disorders 275, 253-254, doi:10.1016/j.jad.2020.06.063 (2020).
16 Lee, C. J., Sears, C. L. & Maruthur, N. Gut microbiome and its role in obesity and insulin resistance. Annals of the New York Academy of Sciences 1461, 37-52, doi:10.1111/nyas.14107 (2020).
17 Cani, P. D. Human gut microbiome: hopes, threats and promises. Gut 67, 1716-1725, doi:10.1136/gutjnl-2018-316723 (2018).
18 Cryan, J. F. et al. THE MICROBIOTA-GUT-BRAIN AXIS. Physiol Rev 99, 1877-2013, doi:10.1152/physrev.00018.2018 (2019).
19 Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054-1062, doi:10.1016/s0140-6736(20)30566-3 (2020).
20 Jie, Z. Y. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8, doi:10.1038/s41467-017-00900-1 (2017).
21 Villette, R. et al. Unraveling Host-Gut Microbiota Dialogue and Its Impact on Cholesterol Levels. Frontiers in Pharmacology 11, doi:10.3389/fphar.2020.00278 (2020).
22 Rieder, R., Wisniewski, P. J., Alderman, B. L. & Campbell, S. C. Microbes and mental health: A review. Brain Behavior and Immunity 66, 9-17, doi:10.1016/j.bbi.2017.01.016 (2017).
23 Taylor, A. M. & Holscher, H. D. A review of dietary and microbial connections to depression, anxiety, and stress. Nutritional Neuroscience 23, 237-250, doi:10.1080/1028415x.2018.1493808 (2020).
24 Crovesy, L., Masterson, D. & Rosado, E. L. Profile of the gut microbiota of adults with obesity: a systematic review. European Journal of Clinical Nutrition, doi:10.1038/s41430-020-0607-6.
25 Geva-Zatorsky, N. et al. Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell 168, 928-+, doi:10.1016/j.cell.2017.01.022 (2017).
26 Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut Microbiota in Cardiovascular Health and Disease. Circ Res 120, 1183-1196, doi:10.1161/circresaha.117.309715 (2017).
27 Groves, H. T. et al. Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota. Frontiers in Immunology 9, doi:10.3389/fimmu.2018.00182 (2018).
28 Groves, H. T., Higham, S. L., Moffatt, M. F., Cox, M. J. & Tregoning, J. S. Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence. Mbio 11, doi:10.1128/mBio.03236-19 (2020).
29 Hasegawa, K. et al. Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case–control study. BMC Research Notes 10, 325, doi:10.1186/s13104-017-2659-9 (2017).
30 Brown, E. M. et al. Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis. Cell Host & Microbe 25, 668-+, doi:10.1016/j.chom.2019.04.002 (2019).
31 Zuo, T. et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology, S0016-5085(0020)34701-34706, doi:10.1053/j.gastro.2020.05.048 (2020).
32 Cheng, Z. K. J. & Shan, J. 2019 Novel coronavirus: where we are and what we know. Infection 48, 155-163, doi:10.1007/s15010-020-01401-y (2020).
33 Stawicki, S. P. et al. The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis 12, 47-93, doi:10.4103/jgid.jgid_86_20 (2020).
34 Casella, F. Can the COVID-19 Epidemic Be Controlled on the Basis of Daily Test Reports? Ieee Control Systems Letters 5, 1079-1084, doi:10.1109/lcsys.2020.3009912 (2021).
35 Park, S. K. et al. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea. Clin Gastroenterol Hepatol, doi:10.1016/j.cgh.2020.06.005 (2020).
36 Edwards, A. et al. In-field metagenome and 16S rRNA gene amplicon nanopore sequencing robustly characterize glacier microbiota. BioRxiv, 073965 (2019).
37 Wei, T. et al. Package ‘corrplot’. Statistician 56, 316-324 (2017).